Cell & Gene Therapy Frontiers: pDNA and mRNA Synthesis in Single-Use Bioreactors

The development of cell and gene therapy requires a complex supply chain which has started to emerge in Australia. Southern RNA contributes to this local supply chain by providing high quality reagent and CDMO service such as pDNA and mRNA process development, manufacturing, and quality control.

Participants will learn about:

Introduction to Advance Therapy Medicinal Product (ATMP - which includes cell and gene therapy) and how pDNA and mRNA play an important role in the supply chain of ATMPs
Overview of the pDNA and mRNA platform process developed by Southern RNA
Overview of the collaboration with Eppendorf in upstream process development
Quality control requirements and overview of Southern RNA QC platform ensuring the quality of pDNA and mRNA.

Watch the recorded webinar now:

Warto przeczytać

Cell & Gene Therapy Frontiers: pDNA and mRNA Synthesis in Single-Use Bioreactors

Participants will learn about:

Watch the recorded webinar now:

Speakers

Karthik Magudeshwaran; Lead Scientist, Southern RNA

Ananth Sharan; Senior Infield Application Specialist- Asia Pacific & Africa, Eppendorf

Za chwilę opuścisz tę stronę.

Cell & Gene Therapy Frontiers: pDNA and mRNA Synthesis in Single-Use Bioreactors

Participants will learn about:

Watch the recorded webinar now:

Speakers

Karthik Magudeshwaran; Lead Scientist, Southern RNA

Ananth Sharan; Senior Infield Application Specialist- Asia Pacific & Africa, Eppendorf